SEI INVESTMENTS CO - NEUROCRINE BIOSCIENCES INC ownership

NEUROCRINE BIOSCIENCES INC's ticker is and the CUSIP is 64125CAD1. A total of 60 filers reported holding NEUROCRINE BIOSCIENCES INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
SEI INVESTMENTS CO ownership history of NEUROCRINE BIOSCIENCES INC
ValueSharesWeighting
Q1 2022$405,000
+5.2%
309,0000.0%0.00%0.0%
Q4 2021$385,000
-6.1%
309,0000.0%0.00%0.0%
Q3 2021$410,000
-0.7%
309,0000.0%0.00%0.0%
Q2 2021$413,000
-0.5%
309,0000.0%0.00%0.0%
Q1 2021$415,000
+24.6%
309,000
+28.2%
0.00%0.0%
Q4 2020$333,000
+51.4%
241,000
+50.6%
0.00%0.0%
Q3 2020$220,000
-17.3%
160,0000.0%0.00%0.0%
Q2 2020$266,000
+29.8%
160,0000.0%0.00%0.0%
Q1 2020$205,000
-16.3%
160,0000.0%0.00%0.0%
Q4 2019$245,000
+11.9%
160,0000.0%0.00%0.0%
Q3 2019$219,000
+4.3%
160,0000.0%0.00%0.0%
Q2 2019$210,000
-53.0%
160,000
-51.7%
0.00%
-50.0%
Q1 2019$447,000
+120.2%
331,000
+178.2%
0.00%
+100.0%
Q4 2018$203,0000.0%119,0000.0%0.00%0.0%
Q3 2018$203,000
-31.4%
119,000
-42.0%
0.00%0.0%
Q2 2018$296,000205,0000.00%
Other shareholders
NEUROCRINE BIOSCIENCES INC shareholders Q3 2020
NameSharesValueWeighting ↓
III Capital Management 12,500,000$17,262,0003.12%
CSS LLC/IL 24,395,000$33,616,0001.59%
Mint Tower Capital Management B.V. 9,000,000$12,407,0001.46%
Context Partners Fund, L.P. 3,000,000$4,125,0000.90%
Context Capital Management, LLC 3,000,000$4,125,0000.90%
SHENKMAN CAPITAL MANAGEMENT INC 4,258,000$5,971,0000.71%
SSI INVESTMENT MANAGEMENT LLC 5,888,000$8,100,0000.70%
Aequim Alternative Investments LP 3,000,000$4,155,0000.55%
WOLVERINE ASSET MANAGEMENT LLC 32,181,000$44,437,0000.40%
TWO SIGMA SECURITIES, LLC 13,000,000$17,875,0000.36%
View complete list of NEUROCRINE BIOSCIENCES INC shareholders